Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1069 | 1046 | 1105 | 1278 | 1408 | 2720 |
Fund Return | 6.92% | 4.62% | 10.53% | 8.51% | 7.08% | 10.52% |
Place in category | 968 | 188 | 1072 | 362 | 392 | 66 |
% in Category | 69 | 11 | 79 | 32 | 44 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NG Fund Institutional Accumulation | 125.2M | 1.86 | 10.44 | 10.56 | ||
NG Income Fund Institutional Income | 244.78K | 1.86 | 10.44 | 10.57 | ||
Income Fund Exempt 2 Accumulation | 41.74M | 1.91 | 10.72 | 10.84 | ||
Global Income Fund Sterling Income | 331.66M | 1.76 | 9.82 | 9.94 | ||
Income Fund X Accumulation | 3.76M | 2.03 | 11.55 | 11.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.6B | 12.21 | 11.26 | 11.88 | ||
Income Fund X Accumulation | 3.76M | 2.03 | 11.55 | 11.66 | ||
NG Fund Institutional Accumulation | 125.2M | 1.86 | 10.44 | 10.56 | ||
NG Income Fund Institutional Income | 244.78K | 1.86 | 10.44 | 10.57 | ||
Global Income Fund Sterling Income | 331.66M | 1.76 | 9.82 | 9.94 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sanofi | FR0000120578 | 3.31 | 90.87 | +0.08% | |
CME Group | US12572Q1058 | 3.02 | 226.92 | -0.47% | |
Cisco | US17275R1023 | 2.77 | 57.66 | +0.27% | |
Dominion Energy | US25746U1097 | 2.39 | 58.36 | +0.96% | |
Gilead | US3755581036 | 2.39 | 89.75 | +1.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review